$5 Million Available in Cooperative Agreement for Advancement of Cancer Immunotherapy
Grants
Copyright © Targeted News Service, 2019
Copyright © Targeted News Service, 2019
2019-02-21
by MYRA TUGADE
WASHINGTON, Feb. 21 -- The U.S. Department of Health and Human Services' National Institutes of Health announced that it expects to award a cooperative agreement for the advancement of cancer immunotherapy by mitigating immune-related adverse events.
This funding opportunity uses the research project-cooperative agreements mechanism.
The estimated total program funding available was cited as $5 million with a ceiling of $375,000. The agency said the grant was associated . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Feb. 21 -- The U.S. Department of Health and Human Services' National Institutes of Health announced that it expects to award a cooperative agreement for the advancement of cancer immunotherapy by mitigating immune-related adverse events.
This funding opportunity uses the research project-cooperative agreements mechanism.
The estimated total program funding available was cited as $5 million with a ceiling of $375,000. The agency said the grant was associated . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com